Characteristics of exercise intolerance in different subgroups of pulmonary arterial hypertension associated with congenital heart disease

被引:2
|
作者
Zhang, Hong-Da [1 ]
Yan, Yi [2 ,3 ]
He, Yang-Yang [4 ]
Liu, Qian-Qian [1 ]
Peng, Fu-Hua [1 ]
Yan, Xin-Xin [1 ]
Han, Zhi-Yan [1 ,5 ]
机构
[1] Chinese Acad Med Sci & Peking Union Med Coll, Fuwai Hosp, Natl Ctr Cardiovasc Dis, State Key Lab Cardiovasc Dis, Beijing 100037, Peoples R China
[2] Shanghai Jiao Tong Univ, Heart Ctr, Shanghai Childrens Med Ctr, Sch Med, Shanghai 200127, Peoples R China
[3] Shanghai Jiao Tong Univ, Shanghai Inst Pediat Congenital Heart Dis, Sch Med, Shanghai 200127, Peoples R China
[4] Henan Univ, Sch Pharm, Kaifeng 475004, Peoples R China
[5] Fuwai Hosp, Chinese Acad Med Sci, Peking Union Med Coll, Natl Ctr Cardiovasc Dis,Dept Anesthesiol,State Key, 167 Beilishi Rd, Beijing 100037, Peoples R China
基金
中国国家自然科学基金; 中国博士后科学基金;
关键词
Pulmonary arterial hypertension; Congenital heart disease; Exercise intolerance; Cardiopulmonary exercise testing; Peak oxygen uptake; EISENMENGER SYNDROME; ADULTS; SURVIVAL; ERA;
D O I
10.1016/j.ijcard.2022.12.033
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Exercise intolerance is a major manifestation of pulmonary arterial hypertension associated with congenital heart disease (PAH-CHD). We aimed to investigate the characteristics of exercise intolerance in different subgroups of PAH-CHD. Methods: We retrospectively enrolled 171 adult patients with PAH-CHD and 30 age and sex-matched healthy subjects and performed cardiopulmonary exercise testing. Gas exchange parameters, including peak oxygen uptake (peak VO2), anaerobic threshold, and the slope of ventilatory equivalent for carbon dioxide (VE/VCO2 slope), were recorded. Results: The median age of patients at enrollment was 27.8 years, and 131 (76.6%) were female. Peak VO2 was reduced in patients compared to healthy controls (median, 14.8 ml/kg/min versus 26.9 ml/kg/min, p < 0.001). Of all 171 patients, 60 (35.1%) had Eisenmenger syndrome, 35 (20.5%) had PAH associated with systemic-to-pulmonary shunts (PAH-SP), 39 (22.8%) had PAH with small defects (PAH-SD), and 37 (21.6%) had PAH after cardiac defect correction (PAH-CD). Patients with Eisenmenger syndrome had the lowest peak VO2 (p = 0.003) and the highest VE/VCO2 slope (p = 0.012), compared with other patients, representing the worst exercise capacity and ventilatory efficiency. Patients with PAH-SP had the best exercise capacity among the four groups, indicated by the highest peak VO2 (p = 0.003) compared with other patients. Peak VO2 was negatively correlated with pulmonary vascular resistance (r =-0.411, p < 0.001). Conclusions: Exercise capacity was severely reduced in patients with PAH-CHD. Among the four subgroups, patients with Eisenmenger syndrome had the worst exercise capacity and ventilatory efficiency.
引用
收藏
页码:29 / 35
页数:7
相关论文
共 50 条
  • [31] Pulmonary arterial hypertension associated with congenital heart disease: Recent advances and future directions
    Gatzoulis, Michael A.
    Beghetti, Maurice
    Landzberg, Michael J.
    Galie, Nazzareno
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2014, 177 (02) : 340 - 347
  • [32] Survival prospects of pulmonary arterial hypertension associated with congenital heart disease: Insights from the HOPE registry
    Patsiou, Vasiliki
    Arvanitaki, Alexandra
    Farmakis, Ioannis T.
    Anthi, Anastasia
    Demerouti, Eftychia
    Apostolopoulou, Sotiria
    Feloukidis, Christos
    Gourgiotis, Panagiotis
    Papadopoulos, Georgios E.
    Chrysochoidis-Trantas, Thomas
    Mpatsouli, Athina
    Zimpounoumi, Natalia
    Mouratoglou, Sophia-Anastasia
    Brili, Styliani
    Leontsinis, Ioannis
    Stamatopoulou, Vaia
    Mitrouska, Ioanna
    Frogoudaki, Alexandra
    Frantzeskaki, Frantzeska
    Tsangaris, Iraklis
    Simitsis, Panagiotis
    Karyofyllis, Panagiotis
    Bechlioulis, Aris
    Naka, Katerina K.
    Ziakas, Antonios
    Manginas, Athanasios
    Giannakoulas, George
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2025, 421
  • [33] Pulmonary arterial hypertension associated with congenital heart disease: An omics study
    Zhao, Maolin
    Liu, Jian
    Xin, Mei
    Yang, Ke
    Huang, Honghao
    Zhang, Wenxin
    Zhang, Jinbao
    He, Siyi
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2023, 10
  • [34] Therapeutic approaches in adults with congenital heart disease-associated pulmonary arterial hypertension
    Cordina, R. L.
    Celermajer, D. S.
    EUROPEAN RESPIRATORY REVIEW, 2010, 19 (118) : 300 - 307
  • [35] Idiopathic Pulmonary Arterial Hypertension and Pulmonary Arterial Hypertension Associated With Congenital Heart Disease in Chinese Children: Similarities, Differences, and Prognostic Factors
    Gu, Li
    Li, Yuan Yuan
    Gu, Ling
    Xie, Liang
    Liu, Han Min
    FRONTIERS IN PEDIATRICS, 2020, 8
  • [36] The role of cystatin C as a biomarker for prognosis in pulmonary arterial hypertension due to congenital heart disease
    Blok, Ilja M.
    van Riel, Annelieke C. M. J.
    Schuuring, Mark J.
    de Bruin-Bon, Rianne H. A. C. M.
    van Dijk, Arie P. J.
    Hoendermis, Elke S.
    Zwinderman, Aeilko H.
    Mulder, Barbara J. M.
    Bouma, Berm J.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2016, 209 : 242 - 247
  • [37] Pulmonary arterial hypertension in patients with congenital heart disease: current issues and health care situation
    Kaemmerer, H.
    Gorenflo, M.
    Hoeper, M.
    Huscher, D.
    Ewert, P.
    Pittrow, D.
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2013, 138 (23) : 1247 - 1252
  • [38] A binational registry of adults with pulmonary arterial hypertension complicating congenital heart disease
    Strange, G.
    Rose, M.
    Kermeen, F.
    O'Donnell, C.
    Keogh, A.
    Kotlyar, E.
    Grigg, L.
    Bullock, A.
    Disney, P.
    Dwyer, N.
    Whitford, H.
    Tanous, D.
    Frampton, C.
    Weintraub, R.
    Celermajer, D. S.
    INTERNAL MEDICINE JOURNAL, 2015, 45 (09) : 944 - 950
  • [39] Characteristics, treatments and survival of pulmonary arterial hypertension associated with congenital heart disease in China: Insights from a national multicenter prospective registry
    Xie, Feng
    Quan, Ruilin
    Zhang, Gangcheng
    Tian, Hongyan
    Chen, Yucheng
    Yu, Zaixin
    Zhang, Caojin
    Liu, Yuhao
    Zhu, Xianyang
    Wu, Weifeng
    Zhu, Xiulong
    Yang, Zhenwen
    Gu, Qing
    Xiong, Changming
    Han, Huijun
    Cheng, Yingzhang
    He, Jianguo
    Wu, Yanqing
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2023, 42 (07) : 974 - 984
  • [40] Initial experiences with the treatment of pulmonary arterial hypertension in congenital heart disease in Slovenia
    Prokselj, Katja
    Vesel, Samo
    ZDRAVNISKI VESTNIK-SLOVENIAN MEDICAL JOURNAL, 2013, 82 (04): : 218 - 224